A61K 35/12
Materials from mammals
Official title: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
A61K35/12 (Materials from mammals) appears on 13,386 US grants and 26,219 published applications in this corpus.
Search patents in A61K- Granted patents
- 13,386
- Published applications
- 26,219
- Assignees
- 6,953
- Inventors
- 35,539
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 27 | 0 |
| 1978 | 25 | 0 |
| 1979 | 23 | 0 |
| 1980 | 22 | 0 |
| 1981 | 32 | 0 |
| 1982 | 39 | 0 |
| 1983 | 35 | 0 |
| 1984 | 49 | 0 |
| 1985 | 28 | 0 |
| 1986 | 37 | 0 |
| 1987 | 42 | 0 |
| 1988 | 50 | 0 |
| 1989 | 34 | 0 |
| 1990 | 45 | 0 |
| 1991 | 46 | 0 |
| 1992 | 47 | 0 |
| 1993 | 40 | 0 |
| 1994 | 53 | 0 |
| 1995 | 48 | 0 |
| 1996 | 93 | 0 |
| 1997 | 140 | 0 |
| 1998 | 188 | 0 |
| 1999 | 165 | 0 |
| 2000 | 142 | 0 |
| 2001 | 161 | 108 |
| 2002 | 165 | 436 |
| 2003 | 187 | 516 |
| 2004 | 146 | 524 |
| 2005 | 145 | 543 |
| 2006 | 161 | 539 |
| 2007 | 127 | 578 |
| 2008 | 158 | 632 |
| 2009 | 182 | 638 |
| 2010 | 255 | 708 |
| 2011 | 254 | 743 |
| 2012 | 330 | 816 |
| 2013 | 411 | 830 |
| 2014 | 532 | 1009 |
| 2015 | 575 | 1110 |
| 2016 | 570 | 1219 |
| 2017 | 653 | 1210 |
| 2018 | 687 | 1254 |
| 2019 | 821 | 1614 |
| 2020 | 824 | 1574 |
| 2021 | 854 | 1651 |
| 2022 | 769 | 1768 |
| 2023 | 697 | 1589 |
| 2024 | 895 | 1788 |
| 2025 | 781 | 1609 |
| 2026 | 579 | 1213 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61K 35/14Blood3,706
- A61K 35/28Bone marrow2,617
- A61K 35/48Reproductive organs1,703
- A61K 2035/124The cells being hematopoietic, bone marrow derived or blood cellsIndexing code1,382
- A61K 35/37Digestive system1,089
- A61K 35/30Nerves864
- A61K 35/32Bones783
- A61K 35/34Muscles643
All 21 subgroupsShow fewer
- A61K 35/36Skin476
- A61K 2035/122For inducing tolerance or supression of immune responsesIndexing code470
- A61K 35/20Milk426
- A61K 35/44Vessels409
- A61K 35/35Fat tissue398
- A61K 35/13Tumour cells, irrespective of tissue of origin317
- A61K 35/33Fibroblasts297
- A61K 2035/126Immunoprotecting barriersIndexing code286
- A61K 35/22Urine269
- A61K 35/26Lymph145
- A61K 35/42Respiratory system113
- A61K 35/24Mucus79
- A61K 35/55Glands not provided for in groups a61k35/22 - a61k35/54556
Recent patents
- Aqueous solution for cell preservation6 Oct 2026US 12,751,446 B2Promocell GmbH
- Antioxidant and antiviral compositions and methods6 Oct 2026US 12,751,971 B2Mayo Foundation for Medical Education and Research
- Anti-Claudin18.2 antigen-binding fragment or antibody, and use thereof182551196 Oct 2026US 12,751,972 B2Guangzhou Bio-Gene Technology Co., Ltd
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- Composition for use in treating dystrophic epidermolysis bullosa6 Oct 2026US 12,751,974 B2Osaka University
- Concentrated milk protein preparations8 Oct 2026US 2026/0305634 A150G Inc.
- Composition and Method for Topical Trans-spinal Delivery of Nucleic Acids and Small Molecules8 Oct 2026US 2026/0306414 A13P Biotechnologies, Inc.
- Hierarchical fatty acid architecture and mammalian lipid metabolic system for nutritional compositions and methods of use8 Oct 2026US 2026/0306433 A1Goldie Formula Inc.
- Compositions and methods for improving brain health8 Oct 2026US 2026/0306520 A1Societe des Produits Nestle S. A.
- Composition for kidney treatment using omentum, a medical kit for kidney treatment, including the same, and film for kidney treatment, including cured product thereof8 Oct 2026US 2026/0306536 A1Rokit Healthcare Inc.
Most cited
By later US patents
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Plasma protein matrices and methods for their preparation1,406US 7,009,039 B2ProChon Biotech Ltd. · 2006
- Biocompatible devices with foam scaffolds984US 6,054,142 ACyto Therapeutics, Inc. · 2000
- Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers896US 5,410,016 ABoard of Regents, The University of Texas System · 1995
- Central occluder semi-biological heart valve842US 4,612,011 A1986